Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.
about
New Robust and Reproducible Stereological IHC Ki67 Breast Cancer Proliferative Assessment to Replace Traditional Biased Labeling Index.A methodology for comprehensive breast cancer Ki67 labeling index with intra-tumor heterogeneity appraisal based on hexagonal tiling of digital image analysis data.Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast CancerKi67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungsMultiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.Recent developments in proteomic methods and disease biomarkers.Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.Quantification of heterogeneity as a biomarker in tumor imaging: a systematic reviewTreatment-induced cell cycle kinetics dictate tumor response to chemotherapyMachine Learning methods for Quantitative Radiomic Biomarkers.Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancerGastro-duodenal fluid induced nuclear factor-κappaB activation and early pre-malignant alterations in murine hypopharyngeal mucosaValue of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin.New discoveries in the molecular landscape of bladder cancer.Significance of interleukin-33 and its related cytokines in patients with breast cancers.Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.Topical Mitomycin-C enhances subbasal nerve regeneration and reduces erosion frequency in the debridement wounded mouse cornea.The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.Carnegie Mellon University bioimaging day 2014: Challenges and opportunities in digital pathology.Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.A combination of biomolecules enhances expression of E-cadherin and peroxisome proliferator-activated receptor gene leading to increased cell proliferation in primary human meniscal cells: an in vitro studyImpact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer.Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis.An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients.Aberrant Ki-67 expression through 3'UTR alternative polyadenylation in breast cancers.Spotlight on the utility of the Oncotype DX® breast cancer assay.Ki67 Heterogeneity in Estrogen Receptor-Positive Breast Cancers: Which Tumor Type Has the Most Heterogeneity?Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer
P2860
Q30489246-319C6E5C-7EFE-42F3-A8C4-002C46A71093Q31007935-9A1CCA04-52DA-4FA5-B4DC-BDFEBDB5B780Q33767081-9766E8B6-1815-4D12-9905-490F3EE66C28Q33843751-B12B660B-5826-4927-90A3-14A5C4483715Q34454922-DED1BCB6-B758-4917-B6AF-2A07C8559A09Q34593824-A2F7EB60-CD87-47DE-88E7-7DC402ED1F36Q34616067-8A145578-4CB2-4987-8D22-5D1975B18263Q34991446-4135082E-7856-4532-B489-C3A5618ACD11Q35197167-7BC1CEE9-828B-4EBC-8165-D76650C154BBQ35251561-5F7E4896-34C7-4A7B-B93E-79B6BAA4C438Q35350679-263854AB-0DF7-4C51-A224-189B256DD19EQ35740145-A95FFE9E-3AB7-4082-9F63-082C441295C6Q35960448-05619D9E-BA41-43F0-A46A-586A955AE27DQ36559818-68506555-9A6A-4BD1-BE75-9FD4BC38563FQ36905795-9062CCA2-66A7-48BD-AD6D-ACDC12433D10Q37101590-7880CA83-90F0-485E-B494-5B7F84CA01C3Q37578747-3376048F-D161-4DB9-AEE7-6CB2672F21EDQ37700227-9EF810DF-2ED3-499F-A67A-E4A01899F517Q38222834-4BA7A6B3-A49C-4745-8A72-30E26302E978Q38732663-61996833-944D-489D-88B6-B88E42CB3FFDQ38771946-F1999FC3-9B51-4328-96EF-60BBB533D148Q39685538-985AC267-4FF4-43BF-8D9B-FE03BB734B0CQ40224233-3C348A48-78F2-49E0-BE4B-FE2FB892FF2EQ41291930-D309DAED-9ACD-4147-AE3E-4CCF404B19C7Q41639699-1AA4B419-5251-4E45-8EE3-E779DA95561FQ46583139-9E93FCF8-C9FB-4EBC-8FF5-3B5FE29B01EAQ47160829-991E08B8-6B9F-416F-9DD7-1DA7DBC66441Q47205521-BFB8FB6D-02F8-49D4-A938-2BC9A3B7765AQ47270135-7C7EC4D7-B390-4421-8913-372EBA24DB66Q47291975-233E8B03-2944-4B23-A16F-F74A25BED2F8Q51304741-97CDD9C4-FE4E-4964-A807-2ED0C0F8FB1AQ52645773-64CAE024-B582-44F4-99C3-6FF869DD02D6Q52689207-ADF9D677-7096-4B73-BCC7-201EFD9F1017Q52728983-18F92F1A-F07F-4DF5-9DB3-4B3A232C9A01Q53351065-9C34B485-FB26-4729-9911-ECC3375D8893Q58798307-C58D8575-5E6B-49F2-B485-0BECAB652DC8
P2860
Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Quantitative assessment Ki-67 ...... chemotherapy in breast cancer.
@en
Quantitative assessment Ki-67 ...... chemotherapy in breast cancer.
@nl
type
label
Quantitative assessment Ki-67 ...... chemotherapy in breast cancer.
@en
Quantitative assessment Ki-67 ...... chemotherapy in breast cancer.
@nl
prefLabel
Quantitative assessment Ki-67 ...... chemotherapy in breast cancer.
@en
Quantitative assessment Ki-67 ...... chemotherapy in breast cancer.
@nl
P2093
P2860
P1476
Quantitative assessment Ki-67 ...... chemotherapy in breast cancer.
@en
P2093
Brigid Killelea
David L Rimm
Donald R Lannin
Jason R Brown
Michael P DiGiovanna
P2860
P2888
P304
P356
10.1038/LABINVEST.2013.128
P577
2013-11-04T00:00:00Z